RNS Number:3706A
Spacelabs Healthcare Inc.
17 July 2007



Spacelabs Healthcare Announces Trading Update

HAWTHORNE, CA -- (MARKET WIRE) -- July 17, 2007 -- Spacelabs Healthcare, Inc.
(LSE: SLAB) issued a trading update today ahead of announcing its results for
fiscal 2007.

Based upon preliminary unaudited data, the Company expects to report revenues
for the second half of fiscal 2007 of approximately $122.3 million, an increase
of approximately 13% when compared to $108.3 million reported for the second
half of fiscal 2006. For the fiscal year ended June 30, 2007 the Company expects
to report revenues of approximately $233.2 million, an increase of 6% compared
to fiscal 2006. Excluding the revenues contributed by Del Mar Reynolds acquired
in July 2006, and after adjusting for revenues associated with businesses that
were divested at the end of the 1st half of this year, underlying revenues in
the 2nd half are expected to grow by approximately 2% compared to the comparable
period of the prior year, but declined by (6%) for the fiscal year ended June
30, 2007.

The Company has experienced a rebound in the critical North American patient
monitoring business in the fourth quarter of this fiscal year. During the fourth
quarter, total revenue growth for the Company is anticipated to be approximately
17% with underlying organic growth of approximately 8%. During the final quarter
of the year, the Company experienced record revenues and order activity.

The Company is expected to announce its operating results for the second half
and fiscal year ended June 30, 2007 on or around September 10, 2007.

About Spacelabs Healthcare

Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) is an international
developer, manufacturer and distributor of medical equipment and services
including patient monitoring solutions, anesthesia delivery and ventilation
systems, diagnostic cardiology solutions and supplies and accessories selling to
hospitals, clinics and physicians offices. Additionally, the Company provides
ECG laboratory services to pharmaceutical companies undertaking clinical trials,
whereby patient ECG data is recorded analyzed, tabulated and interpreted.

The Company employees approximately 1,250 personnel in offices located in the
UK, Canada, India, France, Germany, Finland, Singapore and the United States.

This press release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Such statements include information
regarding the company's expectations, goals or intentions about the future,
including, but not limited to, the Company's predictions about quarterly and
full-year revenues, cost-cutting measures and other matters. The actual results
may differ materially from those described in or implied by any forward-looking
statement. In particular, the Company has not yet finalized the financial
statements to be included in its annual report on Form 10-K for fiscal year 2007
and certain of the cost-cutting measures it has identified may not ultimately be
implemented or realizable by the Company. Other important factors are set forth
in the Securities and Exchange Commission filings for OSI Systems, Inc. All
forward-looking statements speak only as of the date made, and the Company
undertakes no obligation to update, amend or clarify these forward-looking
statements.

For Further Information

Spacelabs Healthcare, Inc.

Jeremy Norton
Director, Investor Relations
12525 Chadron Ave
Hawthorne, CA 90250

Tel: (310) 349 2237

E: jeremy.norton@spacelabs.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
TSTILFFLDTIDLID
Spacelabs Healthcare (LSE:SLAB)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Spacelabs Healthcare.
Spacelabs Healthcare (LSE:SLAB)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Spacelabs Healthcare.